The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Regulatory News (BCN)

  • There is currently no data for BCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 Oct 2016 07:00

RNS Number : 5700N
Bacanora Minerals Ltd
27 October 2016
 

Bacanora Minerals Ltd

("Bacanora" or the "Company")

Financial Results for the Year ended 30 June 2016

 

Bacanora, the Toronto and London listed (TSX-V: BCN and AIM: BCN) company focused on developing the Sonora Project ('Sonora' or 'the Project') in Mexico into a world class lithium carbonate operation, is pleased to announce its final audited results for the 12 months ended 30 June 2016. These results were prepared in line with International Financial Reporting Standards, and, unless otherwise specified, amounts are expressed in Canadian dollars ("CAD$"). Condensed consolidated financial statements are included further below.

 

The Company's Annual Report and Accounts and Management's Discussion and Analysis for the year ended 30 June 2016 are being printed and will be posted to shareholders in due course. Electronic copies of these documents are available on the Company's website at www.bacanoraminerals.com or on SEDAR at www.sedar.com.

 

FISCAL 2016 HIGHLIGHTS

 

Operational

 

· The Company has successfully completed a 4,000 metre drilling programme at the Sonora Lithium Project, comprising 3,000 metres focused on upgrading a portion of the current mineral resource from the indicated to measured category, in conjunction with 1,000 metres for geotechnical and hydrological drilling for a Feasibility Study ("FS").

 

· A total of 3,896 metres were drilled in 31 in-fill holes on La Ventana; along with 560 metres in 5 geotech holes. 16 more holes are programmed to complete the geotech study. Intercepts of the upper clay range from 6.1 to 49.2 metres in length with an average thickness of 30.8 metres and those for the lower clay range from 3.4 to 26.9 metres with an average thickness of 20.45 metres, these including all of the conducted drilling in this area.

 

· This drilling will update the previously announced Indicated Mineral Resource of 259 Mt averaging 3,200 ppm Li for 4.5 Mt of lithium carbonate equivalent ("LCE"). SRK Consulting (UK) Limited ("SRK") has started to update the resource model and an updated Mineral Resource Estimate ("MRE") is anticipated to be published in calendar Q1 2017 sequential with the commencement of mine planning and open pit designs for the FS.

 

· Battery grade lithium carbonate samples from the Company's pilot plant have been distributed to Japan for preliminary appraisal and testing by potential end-users.

 

· On April 15, 2016, the Company filed on SEDAR the results of the Pre-Feasibility Study ("PFS") for the development of mine and lithium carbonate ("Li2CO3") processing facility at the Sonora Lithium Project ("Project"). The positive results estimate a pre-tax Internal Rate of Return ("IRR") of 29% and an associated pre-tax Net Present Value ("NPV") of US$776 million at an 8% discount rate. The PFS was prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI 43-101"). In addition, the Company filed an amended Mineral Resource Estimate ("MRE") prepared in accordance with NI 43-101 for the Sonora Lithium Project.

 

· The PFS highlighted the strong economic potential of producing up to 35,000 tonnes of battery grade Li2CO3, and up to 50,000 tonnes of potassium sulphate ("K2SO4") per year.

 

· Working with the same consultants that prepared the PFS, the Company has commenced a FS for a two stage mine and processing facility to produce up to 35,000 tpa of lithium carbonate. As part of this study we have completed an infill reserve drilling program, provided lithium carbonate samples to potential end-users, appointed international engineering and technical consultants to undertake the geological resource modeling, metallurgical testwork, mine designs and process engineering, as well as recruited additional technical personnel with lithium development and operating expertise. Ausenco Limited ("Ausenco") has now completed approximately 35% of the FS and is scheduled to have the FS completed in late calendar Q1 2017. The Company is fully financed through to the FS, initial project development and the start of the construction stages.

 

Corporate

 

· On August 4, 2016, the Company announced the sad passing of the Hon. Colin Orr-Ewing, the founder and Chairman of the Company, following a short illness. Mr. James Leahy was appointed to the position of interim non-executive Chairman.

 

· During the fiscal year ended June 30, 2016, the Company experienced some changes to its board of directors. Mr. David Lenigas resigned from the board on December 21, 2015. Mr. Mark Hohnen was formally appointed to the board on 27 April, 2016. Mr. Hohnen brings with him experience in the Japanese, Chinese and Korean markets, all of which play a significant role in the production of lithium ion batteries and the development of electric vehicle technology. On October 17th, 2016, the Company also announced the appointment of Mr. Jamie Strauss (subject to completion of normal regulatory checks) as a non-executive independent director to strengthen the Board.

 

· On September 28, 2016, the Company held its General and Special Annual Meeting, at which the shareholders voted amongst other resolutions, on the Company's previously announced plans to re-domicile its governing corporate jurisdiction from Canada to the UK by means of a Plan of Arrangement. All resolutions were dully passed with the exception of the re-domicile resolution. Accordingly, the proposed re-domicile did not proceed and the Company will remain a Canadian registered company and pursue its corporate objectives as such. The Company's common shares will continue to be traded on TSX-V and AIM stock exchanges.

 

· On September 30, 2016, the Company announced that it has received an unsolicited non-binding indicative proposal (the "Proposal") from Rare Earth Minerals plc ("REM"), an AIM listed investment vehicle with a 19.1% shareholding in the Company, and the Company's 30% partner in its Mexilit and Megalit subsidiaries. The Proposal was for an all-share merger of Bacanora and REM with REM acting as the acquiring entity (via a reverse takeover) and issuing newly issued REM shares to Bacanora's shareholders. The merger exchange ratio proposed by REM was between 135 and 141 REM shares for each outstanding Bacanora share. The Board of Bacanora strongly rejected the Proposal, believing that it significantly undervalued the Company and jeopardized the development of the Company's Sonora Lithium Project.

 

Financial

 

· During the quarter ended December 31, 2015, the Company completed a private placement financing of approximately $17.9 million (approximately £8.8 million) via the placing of 11,476,944 new common shares at a price of $1.51 (£0.77) per share. Through the financing, the Company secured its first major institutional shareholder, M&G Investments, as well as receiving support from existing shareholders.

 

· During the quarter end June 30, 2016, the Company had raised approximately $14.7 million (approximately £7.7 million) via the placing of 9,750,000 units at a price of approximately $1.48 (£0.79) per unit with certain funds and accounts managed by BlackRock. Each unit was comprised of one new common share of the Company and 0.3 of one warrant, with each whole warrant being exercisable into one common share at a price of approximately $1.48 (£0.79) at any time subsequent to July 25, 2016, but on or before September 30, 2016. Accordingly, an aggregate of 9,750,000 common shares and 2,925,000 warrants were issued. On September 30, 2016, all of the 2,925,000 warrants were exercised into 2,925,000 new common shares, for total proceeds of approximately $3,938,200.

 

 

Peter Secker, CEO of Bacanora Minerals, said, "Bacanora continues to transition from an exploration company into a lithium development company. The Feasibility Study for the development of a two stage, 35,000 tonne per annum lithium carbonate producer is now well underway and operations at the Hermosillo pilot plant have produced battery grade material for trials in the Asian market. Bacanora is fully funded for this following successful placings which saw our project endorsed by some significant institutions. Given the lithium market fundamentals, and the advanced nature of our project, we believe we are well positioned to capitalise on the growing demand for this 21st century commodity."

 

For further information, please contact:

 

Bacanora Minerals Ltd.

Peter Secker, CEO

info@bacanoraminerals.com

Cairn Financial Advisers LLP, Nomad

Sandy Jamieson/Liam Murray

 

+44 (0) 20 7213 0880

Numis Securities Ltd,

Broker

John Prior/James Black/Paul Gillam

+44 (0) 20 7260 1000

St Brides Partners, Financial PR Adviser

Frank Buhagiar/ Elisabeth Cowell

+44 (0) 20 7236 1177

Macquarie Capital (Europe) Limited, Corporate Adviser

Raj Khatri

+44 (0) 20 3037 2000

 

 

Consolidated Statements of Financial Position

Expressed in Canadian dollars

 

As at

June 30, 2016

June 30, 2015

 

Assets

 

 

 

Current

 

Cash

$ 28,730,168

$ 9,820,069

 

Cash held in trust (Note 8(b))

-

170,968

 

Other receivables (Note 5(a))

265,342

240,810

 

Deferred costs

102,607

18,506

 

Total current assets

29,098,117

10,250,353

 

Non-current assets

 

Property and equipment (Note 7)

2,364,371

2,570,803

 

Exploration and evaluation assets (Note 8)

17,816,713

11,907,427

 

Total non-current assets

20,181,084

14,478,230

 

Total assets

49,279,201

24,728,583

 

Liabilities and Shareholders' Equity

 

Current liabilities

 

Accounts payable and accrued liabilities (Note 14)

1,041,117

798,763

 

Warrant liability (Note 10(b))

897,323

-

 

Total current liabilities

1,938,440

798,763

 

Non-current liabilities

 

Rehabilitation provision (Note 9)

-

150,000

 

Deferred tax liability (Note 11)

135,000

135,000

 

Total non-current liabilities

135,000

285,000

 

Total liabilities

2,073,440

1,083,763

 

Shareholders' Equity

 

Share capital (Note 10)

57,058,924

24,827,911

 

Contributed surplus (Note 10(e))

3,528,990

657,254

 

Foreign currency translation reserve

574,478

1,695,333

 

Deficit

(13,150,873)

(2,855,397)

 

Attributed to Shareholders of Bacanora Minerals Ltd.

48,011,519

24,325,101

 

Non-controlling interest

(805,758)

(680,281)

 

Total shareholders' equity

47,205,761

23,644,820

 

Total Liabilities and Shareholders' Equity

$ 49,279,201

$ 24,728,583

 

Consolidated Statements of Comprehensive Loss

Expressed in Canadian dollars

For the years ended

June 30, 2016

June 30, 2015

 

Revenue

 

Interest income

$ 114,079

$ 108,403

 

Expenses

 

General and administrative (Note 12)

4,226,962

2,753,173

 

Warrant liability valuation

444,024

-

 

Depreciation (Note 7)

88,887

287,527

 

Stock-based compensation (Note 10(f))

3,277,615

-

 

8,037,488

3,040,700

 

Loss before other items

(7,923,409)

(2,932,297)

 

Foreign exchange (loss) gain

(2,497,544)

191,133

 

Loss before tax

(10,420,953)

(2,741,164)

 

Deferred tax (Note 11)

-

(22,000)

 

Loss for the year

(10,420,953)

(2,763,164)

 

Foreign currency translation adjustment

(1,120,855)

1,447,235

 

Total comprehensive loss

(11,541,808)

$ (1,315,929)

 

 Loss attributable to shareholders of Bacanora Minerals Ltd.

(10,295,476)

(2,740,297)

 

 Loss attributable to non-controlling interest

(125,477)

(22,867)

 

(10,420,953)

$ (2,763,164)

 

Total comprehensive loss attributable to shareholders of Bacanora Minerals Ltd.

(11,416,331)

(1,293,062)

 

Total comprehensive loss attributable to non-controlling interest

(125,477)

(22,867)

 

(11,541,808)

$(1,315,929)

 

Net loss per share (basic and diluted)

$ (0.11)

$ (0.03)

 

See accompanying notes to the consolidated financial statements.

Consolidated Statements of Changes in Shareholders' Equity

Expressed in Canadian dollars

Share Capital

Number of Shares

Amount

Contributed Surplus

Accumulated other comprehensive income

Deficit

Non-controlling interest

Total

Balance, June 30, 2014

63,780,812

$13,713,743

$890,017

$248,098

$(1,750,287)

$(657,414)

$12,444,157

Brokered placement

14,393,940

8,610,601

-

-

-

-

8,610,601

Shares issued as broker's compensation

90,909

141,115

-

-

-

-

141,115

Share issue costs

-

(2,009,435)

1,061,000

-

-

-

(948,435)

Share issued on exercise of options

900,000

578,762

(232,763)

-

-

-

345,999

Share issued on exercise of warrants

5,781,748

3,793,125

(1,061,000)

-

-

-

2,732,125

Foreign currency translation adjustment

-

-

-

1,447,235

-

-

1,447,235

Disposition of interest in subsidiary

-

-

-

-

1,635,187

-

1,635,187

Loss for the year

-

-

-

-

(2,740,297)

(22,867)

(2,763,164)

Balance, June 30, 2015

84,947,409

$24,827,911

$657,254

$1,695,333

$(2,855,397)

$(680,281)

$23,644,820

Brokered placements

21,226,944

32,099,923

-

-

-

-

32,099,923

Shares issued on exercise of options

1,700,000

1,046,880

(405,879)

-

-

-

641,001

Share issue costs

-

(915,790)

-

-

-

-

(915,790)

Stock-based compensation expense

-

-

3,277,615

-

-

-

3,277,615

Foreign currency translation adjustment

-

-

-

(1,120,855)

-

-

(1,509,101)

Loss for the period

-

-

-

-

(10,295,476)

(125,477)

(10,032,707)

Balance, June 30, 2016

107,874,353

$57,058,924

$3,528,990

$574,478

$(13,150,873)

$(805,758)

$47,205,761

 

Consolidated Statements of Cash Flows

Expressed in Canadian dollars

For the years ended

June 30, 2016

June 30, 2015

Cash provided by (used in)

Operating activities

Net loss

$ (10,420,953)

$ (2,763,164)

Depreciation

88,887

287,527

Stock-based compensation expense (Note 10(f))

3,277,615

-

Warrant liability revaluation

444,024

Deferred income tax (Note 11)

-

22,000

(6,610,427)

(2,453,637)

Changes in non-cash working capital

Other receivables

(24,533)

303,905

Prepaid

(84,101)

9,158

Accounts payable and accrued liabilities

242,355

474,049

(6,476,706)

(1,666,525)

Financing activities

Issue of shares, net of expenses

31,637,432

7,803,281

Warrants proceeds

-

2,732,733

Option proceeds

641,001

345,999

Mineral property deposit

-

(544,400)

Disposition of interest in subsidiary

-

1,635,187

32,278,433

11,972,800

Investing activities

Additions to mineral properties (Note 8)

(6,726,203)

(1,941,318)

Reclamation costs

(150,000)

-

Additions to property and equipment (Note 7)

(186,393)

(863,357)

(7,062,596)

(2,804,675)

Increase in cash position

18,739,131

7,501,600

Cash and cash held in trust, beginning of the year

9,991,037

2,489,437

Cash and cash held in trust, end of the year

$ 28,730,168

$ 9,991,037

 

See accompanying notes to the consolidated financial statements.

 

 

Notes to the Consolidated Financial Statements

As at and for the years ended June 30, 2016 and 2015

Expressed in Canadian dollars

 

1. CORPORATE INFORMATION

Bacanora Minerals Ltd. (the "Company" or "Bacanora") was incorporated under the Business Corporations Act of Alberta on September 29, 2008. The Company is dually listed on the TSX Venture Exchange as a Tier 2 issuer and on the AIM Market of the London Stock Exchange, with its common shares trading under the symbol, "BCN" on both exchanges. The address of the Company is 2204 6 Avenue N.W. Calgary, AB T2N 0W9.

 

The Company is an exploration stage mining company engaged in the identification, acquisition, exploration and development of mineral properties located in Mexico. The Company has not yet determined whether its mineral properties contain economically recoverable reserves. The recoverability of amounts capitalized is dependent upon the discovery of economically recoverable reserves, securing and maintaining title in the properties and obtaining the necessary financing to complete the exploration and development of these projects and upon attainment of future profitable production. The amounts capitalized as mineral properties represent costs incurred to date, and do not necessarily represent present or future values.

 

2. BASIS OF PREPARATION

a) Statement of compliance

These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").

 

The audited annual financial statements were authorized for issue by the Board of Directors on October 26, 2016. The Board of Directors has the power and authority to amend these financial statements after they have been issued.

 

b) Basis of measurement

These consolidated financial statements have been prepared on a historical cost basis, except for certain financial instruments that have been measured at fair value. 

 

These consolidated financial statements are presented in Canadian dollars. The functional currency of the Company is the British pound sterling ("GBP") and US dollar for its subsidiaries. The Company's functional currency for the consolidated financial statements was previously the Canadian dollar up until June 30, 2016. The functional currency was changed to GBP given that the Company's expenses and financings are now primarily denominated in this currency.

 

 

3. SIGNIFICANT ACCOUNTING POLICIES

The preparation of consolidated financial statements in compliance with IFRS requires management to make certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in Note 4.

 

a) Basis of consolidation

The consolidated financial statements comprise the financial statements of the Company, 70% of its subsidiary, Mexilit S.A. de C.V. ("Mexilit"), 70% of its subsidiary, Minera Megalit S.A de C.V. ("Megalit"), and through its wholly-owned subsidiary, Mineramex Limited, 99.9% of Minera Sonora Borax, S.A. de

 

C.V. ("MSB"), and 60% of Minerales Industriales Tubutama, S.A. de C.V. ("MIT"). Subsidiaries are consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiary are prepared for the same reporting period as the parent company, using consistent accounting policies. All intercompany balances and transactions are eliminated in full. Losses within a subsidiary are attributed to the non-controlling interest even if that results in a deficit balance. A change in ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.

 

b) Foreign currency

(i) Transactions and balances: 

Transactions in foreign currencies are initially recorded in the functional currency at the rate in effect at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the functional currency spot rate of exchange in effect at the reporting date.

 

Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rate as at the date of the initial transaction. All exchange differences are recorded in net income (loss) for the period.

 

(ii) Translation to presentation currency: 

The results and balance sheet of the subsidiary are translated to the presentation currency as follows:

 

Assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;

 

Share capital is translated using the exchange rate at the date of the transaction; revenue and expenses for each statement of comprehensive income (loss) are translated at average exchange rates; and all resulting exchange differences are recognized in other comprehensive income (loss) in the consolidated statements of comprehensive loss.

 

The Company treats specific inter-company loan balances, which are not intended to be repaid in the foreseeable future, as part of its net investment in a foreign operation and any resulting exchange difference on these balances is recorded in other comprehensive loss. When a foreign entity is sold, such exchange differences are reclassified to income (loss) in the consolidated statements of comprehensive income (loss) as part of the gain or loss on sale.

 

c) Cash and cash held in trust

Cash is comprised of cash held on deposit and other short-term, highly liquid investments with original maturities of three months or less with a Canadian chartered bank, UK bank and Mexican banks. These deposits and investments are readily convertible to known amounts of cash and subject to an insignificant risk of change in value. Cash held in trust represents funds received as part of the Company's investment arrangements but not yet deposited in the Company's Canadian chartered bank account.

 

d) Exploration and evaluation assets

Costs incurred prior to acquiring the right to explore an area of interest are expensed as incurred.

 

Exploration and evaluation assets are intangible assets. Exploration and evaluation assets represent the costs incurred on the exploration and evaluation of potential mineral resources, and include costs such as exploratory drilling, sample testing, activities in relation to the evaluation of technical feasibility and commercial viability of extracting a mineral resource, and general & administrative costs directly relating to the support of exploration and evaluation activities. The Company assesses exploration and evaluation assets for impairment when facts and circumstances suggest that the carrying amount may exceed its recoverable amount. The recoverable amount is the higher of the assets fair value less costs to sell and value in use. Assets are allocated to cash generating units not larger than operating segments for impairment testing.

 

Purchased exploration and evaluation assets are recognized as assets at their cost of acquisition or at fair value if purchased as part of a business combination. They are subsequently stated at cost less accumulated impairment. Exploration and evaluation assets are not amortized. Where the Company's exploration commitments for a mineral property are performed under option agreements with a third party, the proceeds of option payments under such agreements are applied to the mineral property to the extent costs are incurred. The excess, if any, is recorded to the statement of loss. Asset swaps are recognized at the carrying amount of the asset being swapped when the fair value of the assets cannot be determined.

 

Once the work completed to date on an area of interest is sufficient such that the technical feasibility and commercial viability of extracting the mineral resource has been determined, the property is considered to be a mine under development. Exploration and evaluation assets are tested for impairment before the assets are transferred to development property, capitalized expenditure is transferred to mine development assets or capital work in progress.

 

e) Property and equipment

Property and equipment is carried at cost less accumulated depreciation and accumulated impairment losses. The cost of an item of property and equipment consists of the purchase price and any costs directly attributable to bringing the asset to the location and condition necessary for its intended use and an estimate of the costs of dismantling and removing the item and restoring the site on which it is located.

Amortization is provided at rates calculated to expense the cost of property and equipment, less their estimated residual value, using the straight-line method over a five year period.

 

The assets' residual values, useful lives and methods of depreciation are reviewed at each financial year-end, and adjusted prospectively if appropriate.

 

f) Rehabilitation provision

The Company recognizes provisions for contractual, constructive or legal obligations, including those associated with the reclamation of mineral interests (exploration and evaluation assets) and plant and equipment, when those obligations result from the acquisition, construction, development or normal operation of the assets. Initially, a provision for the rehabilitation is recognized at its present value in the period in which it is incurred. Upon initial recognition of the liability, the corresponding provision is added to the carrying amount of the related asset and the cost is amortized as an expense over the economic life of the asset. Following the initial recognition of the rehabilitation provision, the carrying amount of the liability is increased for the passage of time and adjusted for changes to the current market-based discount rate, and amount or timing of the underlying cash flows needed to settle the obligation.

 

g) Provisions

Provisions are recognized when the Company has a present obligation (legal or constructive) that has arisen as a result of a past event and it is probable that a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount of the obligation.

Provisions are measured at management's best estimate of the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the time value of money and the risk specific to the obligation. The increase in any provision due to passage of time is recognized as accretion expense.

 

h) Interest income

Interest income is recorded on an accrual basis using the effective interest method.

 

i) Financial instruments

Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument. Financial assets are derecognized when the contractual rights to the cash flows from the financial asset expire, or when the financial asset and all substantial risks and rewards are transferred. A financial liability is derecognized when it is extinguished, discharged, cancelled or expires.

 

Financial assets and financial liabilities are measured initially at fair value plus transactions costs, except for financial assets and liabilities carried at fair value through profit or loss, which are measured initially at fair value. Financial assets and financial liabilities are subsequently measured as described below.

 

(i) Financial assets

For the purpose of subsequent measurement, financial assets are classified into the following categories upon initial recognition: loans and receivables; financial assets at fair value through profit or loss; held-to-maturity investments; and available-for-sale financial assets.

 

The category determines how the asset is subsequently measured and whether any resulting income or expense is recognized in profit or loss or in other comprehensive income.

 

All financial assets except for those at fair value through profit or loss are subject to review for impairment at least at each reporting date. Financial assets are considered impaired when there is objective evidence that a financial asset or a group of financial assets has been impaired.

 

i. Loans and receivables

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. After initial recognition these are measured at amortized cost using the effective interest method, less provision for impairment, if any.

Loans and receivables comprise cash, cash held in trust, and other receivable.

 

(ii) Financial liabilities

Financial liabilities are measured subsequently at amortized cost using the effective interest method, except for financial liabilities held for trading or designated at fair value through profit or

loss, that are carried subsequently at fair value with gains and losses recognized in profit or loss. The effective interest method is a method of calculating the amortized cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments through the expected life of the financial liability, or, where appropriate, a shorter period.

 

The Company's financial liabilities measured at amortized cost include accounts payables and accrued liabilities and due to related parties. The Company's financial liabilities designated at fair value through profit or loss include warrant liability. The Company currently does not have any financial liabilities classified as held for trading.

 

j) Impairment of assets

i) Financial assets

A financial asset that is not carried at fair value through profit or loss is assessed at each reporting date to determine whether there is objective evidence that it is impaired. A financial asset is impaired if objective evidence indicates that a loss event has occurred after the initial recognition of the asset, and that the loss event had a negative effect on the estimated future cash flows of that asset that can be estimated reliably. An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted at the asset's original effective interest rate. The amount of the impairment loss is recognized in profit or loss. If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognized, the previously recognized impairment loss is reversed through profit or loss, unless the impairment relates to an equity investment.

 

ii) Non-financial assets

At the end of each reporting period, the Company reviews the carrying amounts of its tangible and intangible assets to determine whether there is an indication that the assets are impaired. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment, if any. Where the asset does not generate largely independent cash inflows, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Recoverable amount is the higher of fair value less costs to sell, and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessment of the time value of money and the risks specific to the asset.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognized in profit or loss.

 

With the exception of goodwill, all assets are subsequently reassessed for indications that an impairment loss previously recognized may no longer exist. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset (or cash-generating unit) in prior periods. A reversal of an impairment loss is recognized in profit or loss.

 

k) Income taxes

Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in equity or in comprehensive loss.

 

Current income tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years.

 

Deferred income taxes are calculated based on temporary differences between the carrying amounts of assets and liabilities and their tax bases. However, deferred tax is not recognized on the initial recognition of goodwill, on the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss at the time of the transaction, and on temporary differences relating to investments in subsidiaries and jointly controlled entities where the reversal of these temporary differences can be controlled by the Company and it is probable that reversal will not occur in the foreseeable future.

 

Deferred income tax assets and liabilities are measured, without discounting, at the tax rates that are expected to apply when the assets are recovered and the liabilities settled, based on tax rates that have been enacted or substantively enacted by the reporting date.

 

A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized.

 

Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow the related tax benefit to be utilized.

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to set off current tax assets against current tax liabilities, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities and assets are expected to be settled or recovered.

 

 

 

l) Earnings (loss) per share

Basic loss per share is calculated by dividing the loss attributable to the common shareholders of the Company by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is calculated by adjusting the loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares, which comprise of share options and warrants granted.

 

m) Stock-based payments

i) Stock-based payment transactions

The Company grants stock options to acquire common shares to directors, officers and employees ("equity-settled transactions"). The Board of Directors determines the specific grant terms within the limits set by the Company's stock option plan. The Company's stock-based payment plan does not feature any option for a cash settlement.

 

ii) Equity-settled transactions

The costs of equity-settled transactions are measured by reference to the fair value at the grant date and are recognized, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled, ending on the date on which the relevant persons become fully entitled to the award (the "vesting date"). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the Company's best estimate of the number of equity instruments that will ultimately vest. The profit or loss charge or credit for a period represents the movement in cumulative expense recognized as at the beginning and end of that period and the corresponding amount is represented in share option reserve. No expense is recognized for awards that do not ultimately vest.

 

Where the terms of an equity-settled award are modified, the minimum expense recognized is the expense as if the terms had not been modified. An additional expense is recognized for any modification which increases the total fair value of the stock-based payment arrangement, or is otherwise beneficial to the employee as measured at the date of modification.

 

Where equity-settled transactions are awarded to employees, the fair value of the options at the date of grant is charged to profit or loss over the vesting period. Performance vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of the options that will eventually vest.

 

Where equity-settled transactions are entered into with non-employees and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the equity instruments issued. Otherwise, stock-based payments to non-employees are measured at the fair value of the goods or services received.

 

Upon exercise of stock options, the proceeds received are allocated to share capital along with any value previously recorded in share option reserve relating to those options. The dilutive effect of outstanding options is reflected as additional dilution in the computation of diluted earnings per share.

 

n) Segment reporting

The reportable segments identified make up all of the Company's activities and are based on the Company's management structures and the consequent reporting to the Chief Operating Decision Maker, the Board of Directors.

 

Non-current segment assets comprise the non-current assets used directly for segment operations, including intangible assets, property and equipment. Current segment assets comprise the current assets used directly for segment operations, including accounts receivable and deferred costs. Inter-company balances comprise transactions between operating segments making up the reportable segments. These balances are eliminated to arrive at the figures in the consolidated accounts.

 

o) Standards, amendments and interpretations not yet effective

At the date of authorization of these financial statements, certain new standards, amendments and interpretations to existing standards have been published but are not yet effective, and have not been adopted early by the Company.

 

Management anticipates that all of the pronouncements will be adopted in the Company's accounting policy for the first period beginning after the effective date of the pronouncement. Information on new standards, amendments and interpretations that are expected to be relevant to the Company's financial statements are provided below.

 

· IFRS 9, "Financial Instruments ("IFRS 9"). IFRS 9 provides a comprehensive new standard for accounting for all aspects of financial instruments. IFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost or fair value, and replaces the multiple category and measurement models in IAS 39. The approach in IFRS 9 focuses on how an entity manages its financial instruments in the context of its business model, as well as the contractual cash flow characteristics of the financial assets. The new standard also requires a single impairment method to be used, replacing the multiple impairment methods currently provided in IAS 39.

 

· Although the classification criteria for financial liabilities did no change under IFRS 9, the fair value option requires different accounting for changes to the fair value of a financial liability resulting from changes to an entity's own credit risk.

 

The amendments to IFRS 9 are effective for annual periods beginning on or after January 1, 2018 and are available for earlier adoption. The Company is assessing the effect, if any, that the implementation of IFRS 9 may have on the Company's financial statements.

 

· IFRS 15, "Revenue from Contracts with Customers" ("IFRS 15"). In May 2014, the IASB issued IFRS 15. IFRS 15 provides a single model to determine how and when an entity should recognize revenue, as well as requiring entities to provide more informative, relevant disclosures in respect to its revenue recognition criteria. IFRS 15 is to be applied prospectively and is effective for annual periods beginning on or after January 1, 2018, with earlier application permitted. The Company is in the process of evaluating the impact that IFRS 15 may have on the Company's financial statements.

· The IASB has developed a new standard, IFRS 16 "Leases", which supersedes IAS 17 "Leases". The IASB worked jointly with the FASB on this project. IFRS 16 sets out principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer ('lessee') and the supplier ('lessor'). Lessee accounting will change substantially under this new standard while there is little change for the lessor. IFRS 16 eliminates the classification of leases as either operating leases or financing leases and, instead, introduces a single lessee accounting model. A lessee will be required to recognize assets and liabilities for all leases with a term of more than 12 months (unless the underlying asset is of low value) and will be required to present depreciation of leased assets separately from interest on lease liabilities in the statement of income (loss). A lessor will continue to classify its leases as operating leases or financing leases, and to account for those two types of leases separately.

 

IFRS 16 is effective for fiscal periods beginning on or after January 1, 2019. The Company is in the process of evaluating the impact that IFRS 16 may have on the Company's financial statements.

 

4. CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS

The preparation of the Company's financial statements in accordance with IFRS requires management to make certain judgments, estimates, and assumptions about recognition and measurement of assets, liabilities, income and expenses. The actual results are likely to differ from these estimates. Information about the significant judgments, estimates, and assumptions that have the most significant effect on the recognition and measurement of assets, liabilities, income and expenses are discussed below.

 

a) Exploration and evaluation assets

The Company is in the process of exploring its mineral properties and has not yet determined whether the properties contain economically recoverable mineral reserves. The recoverability of carrying values for mineral properties is dependent upon the discovery of economically recoverable mineral reserves, the ability of the Company to obtain the financing necessary to complete exploration and development, and the success of future operations.

 

The application of the Company's accounting policy for exploration and evaluation assets requires judgment in determining whether it is likely that costs incurred will be recovered through successful exploration and development or sale of the asset under review when assessing impairment. Furthermore, the assessment as to whether economically recoverable reserves exist is itself an estimation process. Estimates and assumptions made may change if new information becomes available. If, after expenditures are capitalized, information becomes available suggesting that the recovery of expenditures is unlikely, the amount capitalized is written off in the statement of comprehensive loss in the period when the new information becomes available. The carrying value of these assets is detailed in Note 8.

 

b) Title to mineral property interests

 

Although the Company has taken steps to verify the title to the exploration and evaluation assets in which it has an interest, in accordance with industry practices for the current stage of exploration of such properties, these procedures do not guarantee the Company's title. Title may be subject to unregistered prior agreements or transfers and title may be affected by undetected defects.

 

c) Rehabilitation provision

Rehabilitation or similar liabilities are estimated based on the Company's interpretation of current regulatory requirements, constructive obligations and are measured at fair value. Fair value is determined based on the net present value of estimated future cash expenditures for the settlement of decommissioning, restoration or similar liabilities that may occur upon decommissioning of the mine. Such estimates are subject to change based on changes in laws and regulations.

 

d) Functional currency

The Company transacts in multiple currencies. The assessment of the functional currency of each entity within the consolidated group involves the use of judgment in determining the primary economic environment each entity operates in. The Company first considers the currency that mainly influences sales prices for goods and services, and the currency that mainly influences labour, material and other costs of providing goods or services. In determining functional currency the Company also considers the currency from which funds from financing activities are generated, and the currency in which receipts from operating activities are usually retained. When there is a change in functional currency, the Company exercises judgment in determining the date of change.

 

e) Share-based payments

The Company utilizes the Black-Scholes Option Pricing Model to estimate the fair value of stock options granted to directors, officers and employees. The use of the Black-Scholes Option Pricing Model requires management to make various estimates and assumptions that impact the value assigned to the stock options including the forecast future volatility of the stock price, the risk-free interest rate, dividend yield and the expected life of the stock options. Any changes in these assumptions could have a material impact on the share-based payment calculation value.

 

The same estimates are required for transactions with non-employees where the fair value of the goods or services received cannot be reliably determined and for the warrant derivative liability.

 

f) Income taxes

The Company is subject to income tax in several jurisdictions and significant judgment is required in determining the provision for income taxes. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. In the prior year these transactions included the transfer of properties between Mexican subsidiaries. Transactions between the Company's Mexican subsidiaries are required by Mexican tax rules to be recorded on an arms' length basis and the Company made estimates as to the measurement of these transactions. The Company recognizes liabilities and contingencies for anticipated tax audit issues based on the Company's current understanding of the tax law. Despite the Company's belief that its tax return positions are supportable, the Company acknowledges that certain positions may potentially be challenged and may not be fully sustained upon review by tax authorities. The Company believes that its accruals for tax liabilities are adequate for all open audit years based on its assessment of many factors including past experience and interpretation of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. For matters where it is probable that an adjustment will be made, the Company records its best estimate of the tax liability including the related interest and penalties in the current tax provision. Management believes they have adequately provided for the probable outcome of these matters; however, the final outcome may result in a materially different outcome than the amount included in the tax liabilities, and such differences will impact income tax expense in the period in which such determination is made.

 

In addition, the Company recognizes deferred tax assets relating to tax losses carried forward to the extent there are sufficient taxable temporary differences (deferred tax liabilities) relating to the same taxation authority and the same taxable entity against which the unused tax losses can be utilized.

 

5. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

This note presents information about the Company's exposure to credit, liquidity and market risks arising from its use of financial instruments and the Company's objectives, policies and processes for measuring and managing such risks.

 

a) Credit risk

Credit risk arises from the potential that a counter party will fail to perform its obligations. The Company's credit risk relates solely to Input Tax Credits ("ITC") receivables in Canada and Value Added Tax ("VAT") receivables in Mexico. Any changes in management's estimate of the recoverability of the amount due will be recognized in the period of determination and any adjustment may be significant. The carrying amount of other receivables represent the maximum credit exposure.

 

All of the other receivables represent amounts due from the Canadian and Mexican governments and accordingly the Company believes them to have minimal credit risk. The Company considers all of its other receivables fully collectible, and therefore has not provided an allowance against this balance nor reclassified the balance as a non-current asset.

 

The Company's cash is held in major Canadian, UK and Mexican banks, and as such the Company is exposed to the risks of those financial institutions. The Board of Directors monitors the exposure to credit risk on an ongoing basis and does not consider such risk significant at this time. The Company considers all of its accounts receivables fully collectible.

 

b) Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company's approach to managing liquidity risk is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses. Liquidity risk arises primarily from accounts payable and accrued liabilities and commitments, all with maturities of one year or less.

 

c) Market risk

Market risk is the risk that changes in market prices, such as foreign exchange rates, commodity prices, and interest rates will affect the value of the Company's financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable limits, while maximizing long-term returns.

 

The Company conducts exploration projects in Mexico. As a result, a portion of the Company's expenditures, accounts receivables, accounts payables and accrued liabilities are denominated in US dollars and Mexican pesos and are therefore subject to fluctuation in exchange rates. As at June 30, 2016, a 5% change in the exchange rate between GBP and US dollar would have an approximate $2,353,000 (2015 - $545,000) change to the Company's total comprehensive loss.

 

d) Fair values

The carrying value approximates the fair value of the financial instruments due to the short term nature of the instruments.

 

 

6. CAPITAL MANAGEMENT

The Company's objectives in managing capital are to safeguard its ability to operate as a going concern while pursuing exploration and development and opportunities for growth through identifying and evaluating potential acquisitions or businesses. The Company defines capital as the Company's shareholders equity excluding contributed surplus, of $44,482,529 at June 30, 2016 (2015 - $23,667,847). The Company sets the amount of capital in proportion to risk and corporate growth objectives. The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. The Company is not subject to any externally imposed capital requirements.

 

7. PROPERTY AND EQUIPMENT

Cost

Building and equipment

Office furniture and equipment

Computer equipment

Transportation equipment

Total

Balance, June 30, 2014

$ 1,640,127

$ 3,147

$ 7,992

$ 132,939

$ 1,784,205

Additions

1,291,927

-

3,472

13,457

1,308,856

Balance, June 30, 2015

$ 2,932,054

$ 3,147

$ 11,464

$ 146,396

$ 3,093,061

Additions

108,777

-

17,840

59,776

186,393

Foreign exchange

(267,264)

-

(18,765)

(17,909)

(303,938)

Balance, June 30, 2016

$ 2,773,567

$ 3,147

$ 10,539

$ 188,263

$ 2,975,516

 

Accumulated depreciation

Building and equipment

Office furniture and equipment

Computer equipment

Transportation equipment

Total

Balance, June 30, 2014

$ 133,512

$ 2,432

$ 6,513

$ 92,274

$ 234,731

Additions

278,524

715

1,330

6,958

287,527

Balance, June 30, 2015

$ 412,036

$ 3,147

$ 7,843

$ 99,232

$ 522,258

Additions

80,591

-

2,696

5,600

88,887

Balance, June 30, 2016

$ 492,627

$ 3,147

$ 10,539

$ 104,832

$ 611,145

 

Carrying amounts

Building and equipment

Office furniture and equipment

Computer equipment

Transportation equipment

Total

At June 30, 2015

$ 2,520,018

$ -

$ 3,621

$ 47,164

$ 2,570,803

At June 30, 2016

$ 2,280,940

$ -

$ -

$ 83,431

$ 2,364,371

 

 

8. EXPLORATION AND EVALUATION ASSETS

The Company's mining claims consist of mining concessions located in the State of Sonora, Mexico. The specific descriptions of such properties are as follows:

 

a) Magdalena Borate property

Originally referred to as San Francisco and El Represo projects, Magdalena Borate project consists of eight concessions, with a total area of 7,105 hectares. The concessions are 100% owned by MSB. The Magdalena property is subject to a 3% gross overriding royalty payable to Minera Santa Margarita S.A. de C.V., a subsidiary of Rio Tinto PLC, and a 3% gross overriding royalty payable to the estate of the past Chairman of the Company on sales of borate produced from this property.

 

b) Sonora Lithium property

The Sonora Lithium Project consists of ten contiguous mineral concessions. The Company through its wholly-owned Mexican subsidiary, MSB, has a 100% interest in two of these concessions: La Ventana and La Ventana 1, covering 1,820 hectares. Of the remaining concessions, five are owned 100% by Mexilit, El Sauz, El Sauz 1, El Sauz 2, Fleur and Fleur 1 covering 6,334 hectares. Mexilit is owned 70% by Bacanora and 30% by Rare Earth Minerals PLC ("REM"). In 2014, REM made payment of USD$2,250,000 (CAD$2,384,775) to acquire the 30% interest in Mexilit of which USD$500,000 (CAD$500,000) was received in the year ended June 30, 2013 and was recorded as mineral property deposit. Of the total amount received, USD$1,500,000 (CAD$1,500,000) was restricted for expenditures on Mexilit concessions and spent in fiscal 2015.

 

The remaining three concessions, Buenavista, Megalit and San Gabriel, cover 89,235 hectares, and are subject to a separate agreement between the Company and REM. As at June 30, 2016, Buenavista and San Gabriel concessions were transferred from MSB to Megalit, while the Megalit concession was in the process of being transferred to Megalit. At June 30, 2014, REM owned 10% of Megalit for a payment of USD$750,000 (CAD$829,350). In fiscal 2015 REM increased its holdings of Megalit to 30% of the common shares with a payment of USD$1,500,000 (CAD$1,635,187) of which USD$500,000 (CAD$544,400) was received in fiscal 2014 and was presented as mineral property deposit as at June 30, 2014. USD$1,500,000 (CAD$1,635,187) of the funds received were required to be used only for expenditures in the Megalit concession. As at June 30, 2016, $1,048,780 (2015 - $170,968) of the Company's cash is restricted to be spent on Megalit.

 

The change in ownership interest of Mexilit and Megalit in the prior year did not result of a loss of control and as such have been accounted for as equity transactions.

 

The Sonora Lithium property is subject to a 3% gross overriding royalty on production from certain concessions within the Sonora Lithium property payable to the estate of the past Chairman of the Company.

 

The balance of investment in mining claims as of June 30, 2016 and June 30, 2015 corresponds to concession payments to the federal government, deferred costs of exploration and paid salaries, and consists of the following:

 

 

 

 

Magdalena Borate

La Ventana Lithium

Mexilit Lithium

Megalit Lithium

Total

Balance, June 30, 2014

$ 6,179,591

$ 610,661

$ 2,051,522

$ -

$ 8,841,774

Additions

1,066,567

1,321,176

40,005

637,905

3,065,653

Balance, June 30, 2015

$ 7,246,158

$ 1,931,837

$ 2,091,527

 $ 637,905

$ 11,907,427

Additions:

1,015,692

4,505,946

1,078,990

125,575

6,726,203

Foreign exchange

(537,109)

(60,295)

(186,935)

(32,578)

(816,917)

Balance, June 30, 2016

$ 7,724,741

$ 6,377,488

$ 2,983,582

$ 730,902

$ 17,816,713

 

9. REHABILITATION PROVISION

The Company records a liability for the estimated site rehabilitation costs, discounted to net present value. The net present value is determined using the liability-specific risk-free interest rate. The site rehabilitation costs consists of slope stabilization, re-contouring and seeding waste piles, and stabilizing and monitoring tailings disposal sites. During the year ended June 30, 2016, the Company completed the rehabilitation on the one concession for which it was required. The present value of the obligation was estimated at approximately $Nil (2015 - $150,000).

 

10. SHARE CAPITAL

a) Authorized

The authorized share capital of the Company consists of an unlimited number of voting common shares without nominal or par value.

b) Common Shares Issued

Shares

Amount

Balance, June 30, 2014

63,780,812

$ 13,713,743

Shares issued in Brokered placement issued for cash(1)

14,393,940

8,610,601

Shares issued for share issuance

90,909

141,115

Share issue costs

-

(2,009,435)

Shares issued on exercise of warrants

5,781,748

3,793,125

Shares issued on exercise of options

900,000

578,762

Balance, June 30, 2015

84,947,409

$ 24,827,911

Shares issued on exercise of options

850,000

355,410

Shares issued in private placement for cash(2)

11,476,944

17,871,564

Shares issued on exercise of options

850,000

691,470

Shares issued in private placement for cash(3)

9,750,000

14,228,359

Share issue costs

-

(915,790)

Balance, June 30, 2016

107,874,353

$ 57,058,924

 

(1) On July 25, 2014, the Company completed a brokered financing of 14,393,940 common shares at a price of $0.60 (£0.33) per share for aggregate gross proceeds of $8,610,601 (£4,750,000). Upon completion of this offering, the Company paid cash commissions to its broker, in the amount of $366,153 (£200,500) and issued 90,909 common shares at a price $0.60 (£0.33) per share and 390,874 non-transferrable warrants ("Broker Warrants"). In addition, the Company paid its Nominated Advisor, a corporate finance fee in the amount of $146,096 (£80,000) and issued 390,874 Broker Warrants. Each Broker Warrant entitles the holder to purchase one common share at a price of $0.60 (£0.33) until July 25, 2019. Included in the share issue costs are a total of $1,061,000 relating to the issuance of 781,748 warrants to the Company's brokers, all of which were exercised during the year. In relation to the private placement, the Company issued 90,909 shares to its advisor which were valued at $141,115 and included in share issue costs. The Company also had $295,071 of share issue costs relating to legal matters involved with the Company's private placement.

 

(2) On November 13, 2015, the Company completed a private financing of 11,476,944 common shares at a price of $1.56 (£0.77) per share for aggregate gross proceeds of $17,871,564 (£8,837,247). The Company paid commission of $354,280 and other share issue expenses of $56,117. As part of the financing, 1,973,407 common shares were acquired by REM, a company that is a significant shareholder and has a position in the Company's Board of Directors.

 

(3) On May 20, 2016, the Company completed a private financing that raised approximately $14,681,700 (£7,702,500) via the placing of 9,750,000 units (the "Placing Units") at a price of approximately $1.48 (£0.79) per Placing Unit (the "Placing"). Each Placing Unit is comprised of one new common share of the Company (a "Placing Share") and 0.3 of one common share purchase warrant, with each whole warrant (a "Placing Warrant") being exercisable into one common share at a price of approximately $1.48 (£0.79) at any time subsequent to July 25, 2016, but on or before September 30, 2016. Accordingly, an aggregate of 9,750,000 Placing Shares and 2,925,000 Placing Warrants were issued under this Placing $64,940.

 

The Placing Warrants are denominated in a currency different than the functional currency and are recorded as warrant liability of $453,299, which was measured using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate: 0.39%; expected volatility: 38%; expected life: 4 months; fair value per warrant: $0.15.

 

The fair value of the warrant liability was re-measured as at June 30, 2016 to be $897,323 using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate: 0.25%; expected volatility: 44%; expected life: 3 months; fair value per warrant: $0.31.

 

 

 

 

c) Stock options

The following tables summarize the activities and status of the Company's stock option plan as at and during the year ended June 30, 2016.

Number of options

Weighted averageexercise price

Balance, June 30, 2014

3,425,000

$ 0.35

Exercised

(900,000)

0.38

Expired

(50,000)

0.25

Balance, June 30, 2015

2,475,000

$ 0.38

Exercised

(1,700,000)

0.33

Expired

(50,000)

1.58

Issued

4,250,000

1.75

Balance, June 30, 2016

4,975,000

$ 1.52

 

Grant date

Number outstanding at June 30, 2016

Exercise price

Weighted average remaining contractual life (Years)

Expiry date

Number exercisable at June 30, 2016

September 28, 2012

50,000

0.25

1.5

Sept. 28, 2017

50,000

September 11, 2013

725,000

0.30

2.2

Sept. 11, 2018

725,000

December 2, 2015

1,200,000

1.58

4.4

Dec. 2, 2020

1,200,000

January 22, 2016

1,000,000

1.56(1)

1.6

Jan. 22, 2018

1,000,000

April 27, 2016

2,000,000

1.94(2)

2.9

May 27, 2019

-

4,975,000

2,975,000

(1) Exercise price of £0.77 per share

(2) Exercise price of £0.96 per share

 

d) Warrants

The fair value of broker warrants were determined at the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

June 30, 2016

June 30, 2015

Risk-free interest rate

-

1.91%

Expected volatility

-

109%

Expected life

-

5 years

Fair value per option

-

$1.36

 

The following tables summarize the activities and status of the Company's warrants as at and during the year ended June 30, 2016.

 

Number of warrants

Remaining contractual life (Years)

Expiry date

Weighted average exercise price

Balance, June 30, 2014

5,833,333

2.8

March 26, 2018

$ 0.45

Issued

781,748

4.1

July 25, 2019

$ 0.61

Exercised

(5,781,748)

-

-

$ 0.47

Balance, June 30, 2015

833,333

2.8

March 26, 2018

$ 0.45

Issued

2,925,000

0.3

September 30, 2016

$ 1.51

Balance, June 30, 2016

3,758,333

$ 1.27

 

Grant date

Number outstanding at June 30, 2015

Exercise price

Weighted average remaining contractual life (Years)

Expiry date

Financing warrants

March 26, 2013

833,333

$ 0.45

2.8

March 26, 2018

833,333

May 20, 2016

2,925,000

$ 1.51(1)

0.3

September 30, 2016

2,925,000

June 30, 2016

3,758,333

-

-

-

3,758,333

(1) Exercise price of £0.79 per warrant

 

e) Contributed surplus

The following table presents changes in the Company's contributed surplus.

June 30, 2016

June 30, 2015

Balance, beginning of year

$ 657,254

$ 890,017

Granting of warrants

-

1,061,000

Exercise of warrants

-

(1,061,000)

Exercise of stock options

(405,879)

(232,763)

Stock-based compensation expense

3,277,615

-

Balance, end of year

$ 3,528,990

$ 657,254

 

f) Stock-based compensation expense

During the year ended June 30, 2016, the Company recognized $3,277,615 (2015 - $Nil) of stock-based compensation expense. The fair value of the stock-based compensation was estimated on the dates of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

June 30, 2016

June 30, 2015

Risk-free interest rate

0.45% - 0.89%

-

Expected volatility

123% - 139%

-

Expected life

2 - 5 years

-

Fair value per option

$1.02 - $1.35

-

Expected volatility is based on historical volatility of the Company's stock prices.

 

g) Per share amounts

Basic loss per share is calculated using the weighted average number of shares of 102,255,672 for the year ended June 30, 2016 (2015 - 81,969,138). Options and warrants were excluded from the dilution calculation as they were anti-dilutive.

 

11. INCOME TAXES

The income tax provision differs from income taxes which would result from applying the expected tax rate to net loss before income taxes. The differences between the expected income tax expenses and the actual income tax provision are summarized as follows:

June 30,

2016

2015

Loss before tax

$ (10,420,953)

$ (2,741,164)

Expected income tax recovery at 27% (2014 - 25%)

(2,813,657)

(689,358)

Non-deductible expenses and others

1,085,040

-

Foreign exchange

203,786

Difference from foreign operations

34,735

(31,349)

Rate changes

-

(130,759)

Change in deferred tax asset not recognized

1,490,096

873,466

Total income taxes

-

$ 22,000

 

The components of the Company's net future income tax asset (liability) are as follows:

 

June 30,

2016

2015

Canada

Share issuance costs

$ 374,838

$ 243,083

Unrealized foreign exchange

253,880

64,425

Non-capital losses available for future periods

2,798,090

1,640,729

Unrecognized deferred tax asset

(3,426,808)

(1,948,237)

Canada net deferred income tax asset

-

$ -

Mexico

Property and equipment

$ (183,944)

$ (145,567)

Exploration and evaluation assets

(1,415,757)

(863,970)

Unrealized foreign exchange

(28,731)

(32,723)

Non-capital losses available for future periods

1,767,372

1,169,675

Unrecognized deferred tax asset

(273,940)

(262,415)

Mexico net deferred tax liability

(135,000)

(135,000)

Total net deferred tax asset (liability)

$ (135,000)

$ (135,000)

 

As at June 30, 2016, the Company has, for tax purposes, non-capital losses available to carry forward to future years as follows: Canada - $10,363,297 (2015 - $6,202,000) expiring from 2027 to 2036 and Mexico - $5,891,242 (2015 - $3,899,000) expiring from 2020 to 2026.

 

 

12. GENERAL AND ADMINISTRATIVE EXPENSES

The Company's general and administrative expenses include the following:

For the year ended,

June 30, 2016

June 30, 2015

Management fees (Note 14)

$ 1,861,713

$ 705,084

Legal and accounting fees

1,248,410

1,041,619

Investor relations

434,753

427,862

Office expenses

317,977

177,495

Travel and other expenses

364,109

401,113

Total

$ 4,226,962

$ 2,753,173

 

 

13. SEGMENTED INFORMATION

The Company currently operates in one operating segment, the exploration and development of mineral properties in Mexico. The Company has an office in Calgary, and London but it does not generate any revenues or hold any non-current assets at these locations. Management of the Company makes decisions about allocating resources based on the one geographic operating segment. A geographic summary of the identifiable assets by country is as follows:

Exploration and Evaluation Activities

Consolidated

June 30, 2016

June 30, 2015

June 30, 2016

June 30, 2015

Property and equipment

$ 2,364,371

$ 2,570,803

$ 2,364,371

$ 2,570,803

Exploration and evaluation assets

$ 17,816,713

$11,907,427

$17,816,713

$11,907,427

 

14. RELATED PARTY TRANSACTIONS

 

a. Related party expenses

The Company's related parties include directors and officers and companies which have directors in common. Transactions made with related parties are made in the normal course of business and are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties.

 

During the year ended June 30, 2016, directors and management fees in the amount of $1,801,511 (2015 - $705,084) were paid to directors and officers of the Company. Of this amount, $Nil (2015 - $157,353) was capitalized to exploration and evaluation assets, and $1,801,511 (2015 - $547,731) was expensed as general and administrative costs. Of the total amount incurred as directors and management fees, $38,075 (2015 - $58,706) remains in accounts payables and accrued liabilities on June 30, 2016.

 

During the year ended June 30, 2016, the Company paid $44,147 (2015 - $67,723) to a daughter of the past Chairman of the Company. These services were incurred in the normal course of operations for office administrative services. As of June 30, 2016, $Nil (2015 - $Nil) remains in due to this related party.

 

During the year ended June 30, 2016, the Company paid $856,061 (2015 - $978,946) to Grupo Ornelas Vidal S.A. de C.V., a consulting firm of which Martin Vidal, director of the Company and president of MSB, is a partner. These services were incurred in the normal course of operations for geological exploration and pilot plant operation. As of June 30, 2016, $77,416 (2015 - $80,080) remains in accounts payable and accrued liabilities.

 

b. Key management personnel compensation

Key management of the Company are directors and officers of the Company and their remuneration includes the following:

 

For the year ended,

June 30, 2016

June 30, 2015

Directors' fees:

Colin Orr-Ewing

$ 59,706

 $ 60,000

James Leahy

28,011

20,000

Guy Walker

4,396

19,389

Shane Shircliff

16,671

17,500

Derek Batorowski

16,671

17,500

Kiran Morzaria

16,794

12,072

Mark Hohnen

224,058

-

Total directors' fees:

$ 366,307

$ 146,461

Management and consulting fees:

Paul Conroy(1)

$ -

$ 50,000

Peter Secker

972,418

76,442

Martin Vidal

240,336

222,706

Shane Shircliff

-

77,000

Derek Batorowski

222,450

132,475

Total management and consulting fees

$ 1,435,204

$ 558,623

Employee's salary:

Cordelia Orr-Ewing

$ 44,147

$ 67,723

Total employee's salaries

$ 44,147

$ 67,723

Total director's, management's, consultant's and employee's salaries and fees

$ 1,845,658

$ 772,807

Operational consulting fees:

Groupo Ornelas Vidal SA CV

$ 856,061

$ 978,946

Stock-based compensation

$ 2,020,881

$ -

(1) Mr. Conroy resigned his positions as Director and VP, Special Projects on June 20, 2014. He remained with the Company as a consultant until October 31, 2014.

 

As at June 30, 2016, the following options were held by directors of the Company:

 

Date of grant

Exercise price

Number of options

Shane Shircliff

September 11, 2013

December 2, 2015

$0.30

$1.58

200,000

175,000

Martin Vidal

September 11, 2013

December 2, 2015

$0.30

$1.58

200,000

175,000

Derek Batorowski

September 11, 2013

December 2, 2015

$0.30

$1.58

200,000

175,000

Mark Hohnen

December 2, 2015

January 22, 2016

$1.58

$1.94

1,000,000

2,000,000

 

 

15. COMMITMENTS AND CONTINGENCIES

The Company has commitments for lease payments for field offices with no specific expiry dates. The total annual financial commitment resulting from these agreements is $10,735. Additionally, the Company has commitments for lease payments for its UK office in the amount of $49,000 per year until July, 2018.

The properties in Mexico are subject to spending requirements in order to maintain title of the concessions. The capital spending requirement for 2017 is $333,180. The properties are also subject to semi-annual payments to the Mexican government for concession taxes.

 

16. SUBSEQUENT EVENTS

 

On September 30, 2016, 2,925,000 warrants at a price of approximately $1.35 (£0.79) were exercised into 2,925,000 new common shares, for total proceeds of approximately $3,938,200 (£2,310,750).

 

 

 

17. NON-CONTROLLING INTERESTS

The summary financial information for the Company's Mexican subsidiaries MIT, Mexilit, and Megalit is as follows.

MIT

June 30, 2016

June 30, 2015

Current assets

$ 43,357

$ 56,610

Non-current assets

700

700

Current liabilities

-

-

Non-current liabilities

773,854

1,645,924

Accumulated non-controlling interest

182,996

635,326

Loss (income) for the year

-

(50,101)

Net cash flow from operating activities

-

(171)

Net cash flow from financing activities

-

-

Net cash flow from investing activities

-

-

Net change in cash

-

(171)

Cash beginning of year

-

171

Cash end of year

-

-

 

Mexilit

June 30, 2016

June 30, 2015

Current assets

$ 262,744

$ 1,001,481

Non-current assets

3,754,053

2,616,908

Current liabilities

11,010

-

Non-current liabilities

2,391,348

3,540,378

Accumulated non-controlling interest

(127,322)

17,120

Loss (income) for the year

(625,914)

411,656

Net cash flow from operating activities

(772,931)

(53,382)

Net cash flow from financing activities

615,147

597,564

Net cash flow from investing activities

(598,484)

(358,652)

Net change in cash

(756,268)

185,530

Cash beginning of year

977,548

792,018

Cash end of year

221,280

977,548

 

 

 

 

Megalit

June 30, 2016

June 30, 2015

Current assets

$ 231,931

$ 287,806

Non-current assets

608,095

563,027

Current liabilities

197

19,299

Non-current liabilities

515,635

935,369

Accumulated non-controlling interest

86,678

45,565

Loss (income) for the year

(95,931)

(75,787)

Net cash flow from operating activities

572,329

(65,239)

Net cash flow from financing activities

(570,641)

935,370

Net cash flow from investing activities

(45,068)

(639,721)

Net change in cash

(43,380)

230,410

Cash beginning of year

230,410

-

Cash end of year

187,030

230,410

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FEFEDMFMSESS
Date   Source Headline
21st Jan 202212:58 pmRNSUpdate on Ganfeng Offer Acceptances
14th Jan 20225:13 pmRNSHolding(s) in Company
10th Jan 20227:00 amRNSSettlement of Debt Facility
29th Dec 202111:29 amRNSAdmission and PDMR dealing
24th Dec 20218:34 amRNSHolding(s) in Company
23rd Dec 202112:09 pmRNSCancellation of Admission
22nd Dec 202110:49 amRNSHolding(s) in Company
17th Dec 20215:30 pmRNSBacanora Lithium
17th Dec 20212:30 pmRNSForm 8.3 - Bacanora Lithium PLC
17th Dec 202112:22 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
17th Dec 20219:47 amRNSForm 8.5 (EPT/RI)
17th Dec 20218:05 amRNSZinnwald Distribution, Share Issue & Board Changes
17th Dec 20217:00 amRNSOffer becomes unconditional
16th Dec 20213:09 pmRNSForm 8.3 - Bacanora Lithium PLC
16th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
15th Dec 20213:08 pmRNSForm 8.3 - Bacanora Lithium PLC
15th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
14th Dec 20219:56 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
14th Dec 20219:39 amRNSZinnwald Lithium fundraise
13th Dec 202111:14 amRNSForm 8.5 (EPT/RI)
13th Dec 20218:38 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
10th Dec 20213:10 pmRNSForm 8.3 - Bacanora Lithium PLC
10th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
10th Dec 20219:27 amRNSForm 8.5 (EPT/RI)
9th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
9th Dec 202110:48 amRNSForm 8.5 (EPT/RI)
8th Dec 202112:05 pmRNSForm 8.5 (EPT/RI)
8th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
7th Dec 20212:26 pmRNSForm 8.3 - Bacanora Lithium PLC
7th Dec 20212:06 pmBUSForm 8.3 - BACANORA LITHIUM PLC
7th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
7th Dec 20219:25 amRNSForm 8.5 (EPT/RI)
6th Dec 20212:41 pmRNSForm 8.3 - Bacanora Lithium PLC
6th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
6th Dec 20219:43 amRNSForm 8.5 (EPT/RI)
6th Dec 20217:00 amRNSAcceptance level update
3rd Dec 20213:00 pmBUSForm 8.3 - Bacanora Lithium Plc
3rd Dec 20212:18 pmRNSForm 8.3 - Bacanora Lithium PLC
3rd Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
2nd Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
1st Dec 20212:50 pmRNSForm 8.3 - Bacanora Lithium PLC
1st Dec 20212:38 pmBUSFORM 8.3 - BACANORA LITHIUM PLC - AMENDMENT
1st Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
30th Nov 20213:11 pmRNSForm 8.3 - Bacanora Lithium PLC
30th Nov 20212:34 pmBUSForm 8.3 - BACANORA LITHIUM PLC Amendment
30th Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
29th Nov 20212:54 pmRNSForm 8.3 - Bacanora Lithium PLC
29th Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
26th Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
26th Nov 20219:23 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.